Research

DHS Report: Environment unlikely to affect transmissibility of SARS-COV-2 variants

New research from the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) has found that the deactivating effects…

5 hours ago

Interim Phase 3 trial data shows lingering COVID-19 antibodies up to six months after Moderna vaccination

Moderna, Inc. is trumpeting the interim results of a phase three trial of its COVID-19 vaccine, which have shown antibodies…

5 hours ago

WHO labels AstraZeneca COVID-19 vaccine blood clot issues rare, but worth continued study

An assessment by the COVID-19 subcommittee of the World Health Organization (WHO) Global Advisory Committee on Vaccine Safety (GACVS) has…

5 hours ago

Valneva offers positive COVID-19 vaccine candidate data

The specialty vaccine company Valneva SE has issued positive data for Part A of the Phase 1/2 clinical trial of…

1 day ago

DHS funds target biological threats monitoring

The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) has earmarked funds to develop capabilities to monitor the…

2 days ago

DIA outlines latest MARS initiative breakthrough

Defense Intelligence Agency (DIA) officials recently outlined the latest breakthrough regarding its Machine-assisted Analytic Rapid-repository System (MARS) initiative, touting efforts…

2 days ago

Walter Reed-created COVID-19 vaccine begins Phase 1 clinical testing

A new COVID-19 vaccine developed by the Walter Reed Army Institute of Research (WRAIR) began a phase one clinical trial…

2 days ago

BARDA, Janssen expand Phase 2a trial of COVID-19 vaccine to include adolescents

An ongoing Phase 2a trial of a Janssen Pharmaceutical Companies-developed COVID-19 vaccine candidate has been expanded to include adolescents between…

3 days ago

NIH begins Phase 1 clinical trial to test Moderna COVID-19 variant vaccine

Although it already has a successful COVID-19 vaccine in circulation, Moderna is developing a vaccine designed to address the troubling…

4 days ago

NIRVANA diagnostic capable of diagnosing, sequencing COVID-19, variants and other viruses

Clinicians have created a portable test -- dubbed NIRVANA -- capable of detecting and sequencing COVID-19, its variants, and other…

1 week ago

CEPI offers up to $200M for SARS-CoV-2, betacoronavirus vaccine development

The Coalition for Epidemic Preparedness (CEPI) announced this week that it will invest up to $200 million into promising vaccine…

1 week ago

BARDA researching treatment for sulfur mustard corneal injury

Biomedical Advanced Research and Development Authority (BARDA) officials said the agency has provided funding for studies evaluating the therapeutic potential…

1 week ago

CDC awards UCLA $4.9M grant to study COVID-19 vaccine efficacy on health workers

Over the next year, the University of California, Los Angeles (UCLA) will lead a study of COVID-19 vaccine effectiveness on…

1 week ago

Biodefense Commission warns U.S. still vulnerable to further biological threats

Even as the United States reels from a year under the thumb of COVID-19, a new analysis from the Bipartisan…

1 week ago

Moderna ships 100 millionth COVID-19 vaccine dose

Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced Monday that it has shipped the 100 millionth…

1 week ago

Singapore scientists create diagnostic to detect SARS-CoV-2, mutations

Faced with an already mutating SARS-CoV-2 virus, the world has found itself needing to adapt its countermeasures -- and a…

1 week ago

ATOM consortium adds three DOE national laboratories to collaborative AI-driven drug discovery efforts

A total of five national laboratories are now a part of the Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium,…

1 week ago

Rep. Meeks, Sen. Durbin offer input on GAO Mexico firearms trafficking report

Rep. Gregory Meeks (D-NY) and Sen. Dick Durbin (D-IL) have offered thoughts regarding the Government Accountability Office's (GAO) update of…

2 weeks ago

Galveston National Lab confirms combo antibody-remdesivir therapy protects against advanced Marburg virus

According to a new study from the Galveston National Laboratory, published last week in Nature Communications, combining monoclonal antibodies and…

2 weeks ago

GAO reemphasizes need for bolstered cybersecurity

The Government Accountability Office (GAO) is reemphasizing the federal government needs to proceed with greater urgency to bolster cybersecurity initiatives…

2 weeks ago

Primary analysis of AstraZeneca COVID-19 vaccine candidate backs interim data, dismissing U.S. concerns

Moving quickly to tamp down concerns raised by the independent Data Safety Monitoring Board (DSMB) this week, AstraZeneca announced today…

2 weeks ago

Cipla Therapeutics, SIGA Technologies partner to fight biothreats

Cipla Therapeutics, and SIGA Technologies, Inc, announced Tuesday that they would be entering into a strategic partnership to deliver innovation…

2 weeks ago

Northrup Gruman, Lockheed Martin secure DOD agreements for Next Generation Interceptor program

Northrop Grumman Systems and Lockheed Martin have been awarded Department of Defense (DOD) contracts supporting the Next Generation Interceptor (NGI)…

2 weeks ago

Report calls for national priorities to address COVID-19 pandemic misinformation

A recently released Johns Hopkins Center for Health Security at the Bloomberg School of Public Health report is calling on…

2 weeks ago

Regeneron COVID-19 antibody treatment offers 70 percent reduction in hospitalization and death in Phase 3 trial

Topline results from a phase three trial of the Regeneron Pharmaceuticals, Inc. COVID-19 antibody treatment, REGEN-COV, are in, demonstrating 70…

2 weeks ago

Pfizer begins Phase 1 study of oral antiviral therapeutic for use against SARS-CoV-2

Encouraged by its success against SARS-CoV-2 and other coronaviruses in test-tube studies, Pfizer Inc. has launched a phase one study…

2 weeks ago

DHS taps University of Washington to create criteria for COVID-19 digital contact tracing app testing

The Science and Technology Directorate (S&T) of the Department of Homeland Security (DHS) awarded $959,305 to the University of Washington’s…

2 weeks ago

CARB-X funders release plan development guide to tackle threat of antibiotic-resistant bacteria

A Stewardship and Access Plan Development Guide for countering the spread of antibiotic-resistant superbugs was developed and released this week…

2 weeks ago

Sens. Smith, Young introduce One Health legislation to combat disease outbreaks

U.S. Sens. Tina Smith (D-MN) and Todd Young (R-IN) introduced a bill that would improve coordination among government agencies when…

2 weeks ago

TSA aids Connecticut drone detection testing

U.S. Transportation Security Administration (TSA) personnel recently joined Connecticut and New York law enforcement and police departments in aiding the…

2 weeks ago

AstraZeneca’s COVID-19 vaccine 79 percent effective against symptomatic COVID-19 in U.S. study

As the debate over AstraZeneca’s AZD1222 COVID-19 vaccine rages in Europe, the results of a phase three trial in the…

2 weeks ago

Researchers: Vaccines alone may not control pandemic

Two Georgetown University infectious disease experts maintain vaccines alone may not be enough to control the COVID-19 pandemic. Angela L.…

3 weeks ago

Republicans on House E&C Committee urge NIH to join investigation into COVID-19 origins

Pointing the finger firmly at China in the throes of the COVID-19 pandemic, Republican leaders on the House Energy and…

3 weeks ago

IDSA, health partners call on House leaders to increase federal investments for antimicrobial resistance fight

Warning that antibiotic resistance is one of the greatest public health threats of the age, the Infectious Diseases Society of…

3 weeks ago

Agencies release domestic violent extremism report findings

Office of the Director of National Intelligence (ODNI), Department of Justice (DOJ), and Department of Homeland Security (DHS) personnel have…

3 weeks ago

This website uses cookies.